This article provides an overview of recent research on the compound epigallocatechin gallate and its potential to inhibit processes involved in lung cancer progression.
It discusses how this compound might suppress mechanisms like angiogenesis and epithelial-mesenchymal transition that are crucial for cancer cell migration and invasion.